春妮的周末时光

马拉松名额：难道越来越不值钱了？_我的网站

毛骨悚然撞鬼经

一 |

前不久，一家知名金牌赛事给到健康跑吧几个媒体直通名额。这在过去，这些都是"金不换"的硬通货。

The Biden administration is eyeing mid-September for the rollout of updated COVID-19 vaccines, according to Food and Drug Administration and Centers for Disease Control and Prevention officials.

“Vaccination is going to continue to be key this year because immunity wanes and because the COVID-19 virus continues to change,” an official said on a call with reporters. “For those reasons, vaccines remain the best protection against hospitalization and death.”

It’s the first time that vaccines for all three of the major fall and winter viruses – flu, COVID-19 and respiratory syncytial virus – will be available.

The announcement comes as COVID-19 hospitalizations are increasing and the Biden administration hopes to get ahead of any potential fall or winter coronavirus wave with its vaccine campaign.

Moderna, Pfizer and Novavax have developed updated coronavirus vaccines that will target the XBB.1.5 strain, which was responsible for less than 5% of new infections in recent weeks, according to CDC data.

The dominant strain circulating now is EG.5 – nicknamed “eris” – that is causing over 20% of new cases.

Eris appears more transmissible and better able to evade immunity provided by vaccines and previous infection, according to the World Health Organization, but it hasn’t been associated with more severe disease.

Another variant to watch is BA.2.86, which quickly caught the attention of both WHO and the CDC. The highly mutated strain is likely not responsible for the recent rise in hospitalizations in the U.S., according to the CDC, but it is too soon to know the new strain’s transmissibility or severity.

Officials believe the updated shots will work against these strains.

“FDA expects that once available, the updated vaccines will similarly provide protection against the most serious outcomes of the disease that may result from currently circulating variants,” one of the officials said.

The CDC’s committee of outside vaccine experts will meet in mid-September to recommend who should get the updated COVID-19 vaccines. The officials noted that for some people, including older or immunocompromised Americans, more than one shot per year may be needed.

。

二 | 小编熬夜写稿、费心费力换来的"金贵名额"，给谁，不得请个“大餐”，请小编喝两杯。现在可不一样了，名额送出去了，中奖跑友欢天喜地来领，一听"直通但需要交报名费"，转身就走："算了，不要了"。在中签率很低的情况下，白给的直通名额都送不出去。马拉松的名额，难道真的不值钱了？两极分化头部赛事确实一票难求，普通赛事和"搭售式直通"或许才是真正的无人问津。名额的价值正在剧烈分化——"金贵名额"还是金贵的，贬值的只是那些"自己以为很金贵"的名额。马拉松赛事自己制造抽签假象，原来有媒体不断报道，自己捏造更低的中签率，制造跑友焦虑和恐慌。

三 | 这种饥饿营销方法，屡试不爽。很多聪明的跑友从完赛人数的排名，可以推测出真正的参赛人数，有些赛事参赛人数不足规模总数的五成，何来的抽签？赛事好坏，其实中签率不能说明问题，跑友心里自然有杆秤。当所谓的"直通"不再是稀缺资源，而只是"省去抽签"的鸡肋，跑友自然会用脚投票：有些赛事报都报不满，何来的“直通”？跑友清醒很多跑马多年的老司机，参赛的理念不断从"跟风参赛"转向"理性择赛"，选择越来越理性。很多跑友都表示："以前看到比赛就想报名，现在更看重赛道品质、服务保障和城市特色，会精挑细选优质赛事。

四 | "钱要花在刀刃上。

五 | 与其花几千块去跑一场毫无记忆点的赛事，不如攒着钱跑一场真正想要的赛事。

六 | 有些赛事的"名额"不再是稀缺品，"去不去"就成了纯粹的经济账。

七 | 钱包紧了跑圈内卷，很多跑友通过跑步赚不到钱，也就不想花钱了。网红跑者的奇装异服被严管，精英选手的赞助费越来越薄，草根跑团的团报优惠基本绝迹。

八 | 当很多跑友无法通过跑步获得收益，纯支出的参赛就变成了"亏本买卖"。一场赛事，从报名费，到交通费、食宿费，再加上日常的装备费用，一场赛事多则几千块，少则也得大几百。从另一个方面而言，跑友减少参赛的频率，也有另一个好处——省钱。当经济下行撞上跑圈内卷，"花钱买罪受"的性价比急剧下降。行业规范新规之下，马拉松的本质被重新强调，它不是全民健身项目，而是极限运动。很多赛事也在不断提升报名的门槛，报名全马需要提供一年内的A类马拉松赛事的成绩，其他赛事都不算，还需要有健康的体检证明。甚至有些赛事通过中签率，不断刷掉年龄大的跑友。

九 | 赛事对跑友参赛也更加严格了，倡导的赛事各种文明，束缚了很多跑友的自由发挥。

十 | 一些想通过赛事哗众取宠，博流量的跑友，也失去了对马拉松的兴趣。价值回归回到最初的话题，直通名额到底值不值钱？从深层次看：跑友变了。

十一 | 他们不再是那个"有马就跑、有名额就拿"的初学者，而是会算账、会挑选、会权衡的成熟消费者。赛事变了。新政之下，赛事总量在减少，优质赛事在集中，劣质供给在被慢慢地淘汰。名额也变了。当"直通"只是"省一次抽签"，对于报名不满的赛事，就没有了任何价值。真正稀缺的，还是那些"赛道好、组织棒、服务优、城市美"的头部赛事的“直通”。或许，真正优质的参赛“直通”，正在新规和市场的双重筛选中，变得越来越贵、越来越难得。对跑友来说，这其实是好事，不用再为"面子名额"买单，可以把钱和精力，留给真正值得的那场马。毕竟，跑步的初衷是健康与热爱，不是朋友圈的一块奖牌，更不是别人眼里"你有名额"的羡慕。亲爱的跑友，您说呢？欢迎大家留言参与讨论。